Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging, and Epigenetics and DNA Methylation.
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up
Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types
Telomerase reverse transcriptase promoter mutation– and O6-methylguanine DNA methyltransferase promoter methylation–mediated sensitivity to temozolomide in isocitrate dehydrogenase–wild-type glioblastoma: is there a link?
Chemotherapy for adult patients with spinal cord gliomas
The molecular evolution of glioblastoma treated by gross total resection alone
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations
DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i> -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma
Clinical and molecular subgroups of ependymoma in adulthood: An analysis of the German Glioma Network.
Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma.
PATH-24. MOLECULAR SUBGROUPS OF ADULT EPENDYMAL TUMORS: AN ANALYSIS OF THE GERMAN GLIOMA NETWORK
Chemotherapy for intracranial ependymoma in adults
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity
HG-68COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA
DRES-13. EXTENDED TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: AN ANALYSIS OF THE GERMAN GLIOMA NETWORK
MPTH-23. LONG-TERM SURVIVAL WITH GLIOBLASTOMA IN THE ELDERLY
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Gliomatosis cerebri: no evidence for a separate brain tumor entity
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling
NDRG1 prognosticates the natural course of disease in WHO grade II glioma
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy